Marta Garrido

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Journal: Gut
Published: August 25, 2025

IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.

IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.

Journal: The EMBO journal
Published: June 10, 2023

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Journal: Nature communications
Published: January 26, 2023

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Journal: Nature communications
Published: January 25, 2022

Reversing chemorefraction in colorectal cancer cells by controlling mucin secretion.

Reversing chemorefraction in colorectal cancer cells by controlling mucin secretion.

Journal: eLife
Published: September 17, 2021

Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.

Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.

Journal: Nature communications
Published: July 20, 2021

p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis.

p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis.

Journal: Nature communications
Published: March 30, 2021

miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus.

miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: October 22, 2020

IκBα deficiency imposes a fetal phenotype to intestinal stem cells.

IκBα deficiency imposes a fetal phenotype to intestinal stem cells.

Journal: EMBO reports
Published: November 19, 2019

Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation.

Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation.

Journal: Cell reports
Published: October 14, 2019

CDX2 can be regulated through the signalling pathways activated by IL-6 in gastric cells.

CDX2 can be regulated through the signalling pathways activated by IL-6 in gastric cells.

Journal: Biochimica et biophysica acta
Published: February 14, 2014

Activation of the NF-kB pathway downregulates TFF-1 in gastric carcinogenesis.

Activation of the NF-kB pathway downregulates TFF-1 in gastric carcinogenesis.

Journal: Virchows Archiv : an international journal of pathology
Published: April 19, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026